Major General James Gilman, Commanding General of the US Army Medical Research and Material Command, outlined the US army's extensive research efforts in stem cell technologies and their mission to discover, develop and translate regenerative medicine. He spoke about the military's desire to partner with academia and industry to generate effective treatments for volume, bone, muscle and tissue injuries and about spinal cord regeneration as the military's biggest challenge and hope. The rest is here: 2011 Summit: Harnessing Regenerative Medicine for US Service-members, Major General James K. Gilman - Video … Continue reading →

Robert Klein, former chair of the California Institute of Regenerative Medicine (CIRM), presented this year's advocacy keynote, addressing the looming black cloud over funding for stem cell research in the US. Klein explained that in a financial downturn, creating long term, big picture investments for donors is absolutely necessary to bring to new treatment modalities to market. Visit link: 2011 Summit: Government … Continue reading →

Andy Grove, PhD and Former CEO of Intel Corporation, dared to suggest that translational medicine will be a "bridge to nowhere" if the way we handle the development of new drugs does not undergo a serious transformation. He proposed a radical rethinking of our whole regulatory and IP system, encouraging all members of the stem cell community to stimulate action and push for change. Grove asked attendees to consider how stem cell science will live in the current system and to pioneer innovative ways to get therapies to the clinic faster. Read the original: 2011 Summit: Translational Medicine: Key to Progress or Bridge to Nowhere?, Andrew S. Grove, PhD - Video … Continue reading →

2/24/2010-Osiris Therapeutics (NASDAQ:OSIR) said Wednesday according to its most recent study of 52 heart-attack patients, its stem cell therapy Prochymal improved cardiac function and reduced irregular heartbeats compared to a control group. Additionally, a larger Phase II study is underway on patients who have had severe heart attacks Visit link: Osiris (NASDAQ:OSIR) Reports Positive Study Results for Prochymal - Video … Continue reading →